MEREO BIOPHARMA GROUP PLC's ticker is MREO and the CUSIP is 589492107. A total of 57 filers reported holding MEREO BIOPHARMA GROUP PLC in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $75,100 | -2.3% | 58,217 | 0.0% | 0.00% | – |
| Q2 2023 | $76,846 | +87.8% | 58,217 | 0.0% | 0.00% | – |
| Q1 2023 | $40,921 | -5.0% | 58,217 | 0.0% | 0.00% | – |
| Q4 2022 | $43,070 | -17.2% | 58,217 | 0.0% | 0.00% | – |
| Q3 2022 | $52,000 | -27.8% | 58,217 | 0.0% | 0.00% | – |
| Q2 2022 | $72,000 | +10.8% | 58,217 | 0.0% | 0.00% | – |
| Q1 2022 | $65,000 | -31.6% | 58,217 | 0.0% | 0.00% | – |
| Q4 2021 | $95,000 | -30.7% | 58,217 | 0.0% | 0.00% | – |
| Q3 2021 | $137,000 | -23.9% | 58,217 | 0.0% | 0.00% | – |
| Q2 2021 | $180,000 | -8.2% | 58,217 | 0.0% | 0.00% | – |
| Q1 2021 | $196,000 | -7.1% | 58,217 | 0.0% | 0.00% | – |
| Q4 2020 | $211,000 | – | 58,217 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tejara Capital Ltd | 2,188,606 | $1,641,455 | 0.95% |
| Monaco Asset Management SAM | 2,049,661 | $1,537,246 | 0.46% |
| Rubric Capital Management LP | 10,366,120 | $7,774,590 | 0.34% |
| Clearline Capital LP | 2,052,709 | $1,539,532 | 0.28% |
| DAFNA Capital Management LLC | 1,096,513 | $822,385 | 0.23% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 7,364,438 | $5,523,329 | 0.23% |
| Orbimed Advisors | 10,605,522 | $7,954,142 | 0.15% |
| Octagon Capital Advisors LP | 1,000,000 | $750,000 | 0.12% |
| Rock Springs Capital Management LP | 6,244,897 | $4,683,673 | 0.11% |
| Privium Fund Management (UK) Ltd | 177,200 | $132,900 | 0.10% |